Here, we present evidence of alterations in leptin signaling in the peripheral and CNS of the TDP43A315T transgenic ALS mouse model, providing novel insights about the pathways that could link alterations in leptin to ALS disease. This evidence concerns the gene LEP and amyotrophic lateral sclerosis.